Thursday July 15, 1999 - Question 6

Which of the following statements about the clinical presentation of an exposure to cyclopeptide-containing mushroom is true?

A. Symptoms onset is delayed 6-24 hours following the ingestion of a cyclopeptide-containing species.

B. The earliest symptoms of intoxication with a cyclopeptide-containing mushroom are associated with renal failure.

C. Evidence of hepatotoxicity presents 4-7 days following the exposure.

D. Laboratory abnormalities seen following cyclopeptide species exposure include decreases in prothrombin time, bilirubin, BUN, and serum creatinine.

E. Peak transaminase levels are reliable indicators of clinical outcome.
 

Discussion